Crystalvue Medical Corporation (TPEX:6527)
76.80
+0.50 (0.66%)
Jan 22, 2026, 1:18 PM CST
Crystalvue Medical Revenue
Crystalvue Medical had revenue of 200.93M TWD in the quarter ending September 30, 2025, a decrease of -13.80%. This brings the company's revenue in the last twelve months to 905.73M, up 8.65% year-over-year. In the year 2024, Crystalvue Medical had annual revenue of 868.03M with 5.35% growth.
Revenue (ttm)
905.73M
Revenue Growth
+8.65%
P/S Ratio
2.16
Revenue / Employee
8.31M
Employees
109
Market Cap
1.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 868.03M | 44.07M | 5.35% |
| Dec 31, 2023 | 823.96M | 28.51M | 3.58% |
| Dec 31, 2022 | 795.46M | 73.84M | 10.23% |
| Dec 31, 2021 | 721.61M | 217.24M | 43.07% |
| Dec 31, 2020 | 504.37M | -156.74M | -23.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |
| Caliway Biopharmaceuticals | 34.99M |